MassBio

MassBio CEO & President Kendalle Burlin O'Connell, Esq. recently spoke with Adil Ali, MD and Onyx about representing the world's most consequential life sciences ecosystem, MassBio's Vision 2030 strategic roadmap, programs like #MassBioDrive and BioversityMA, and more. Onyx's in-depth report,?Vital Signs: Future of Healthcare, will appear in Fortune magazine in December ahead of JPM Week. ??: https://lnkd.in/eVkggiwv

The #MassBioHub has been fortunate to host these events over the last few weeks - thank you for bringing your science to the Hub! #HubHappenings ?AADC Family Network held their AADC Awareness Day - an event aimed at raising awareness and promoting education about aromatic L-amino acid decarboxylase (AADC) deficiency: https://lnkd.in/eW5rugjF ?CANCollaborate held their 2024 Appendiceal Cancer Workshop: https://cancollaborate.org ?Massachusetts Life Sciences Center hosted a women's health event: https://lnkd.in/eW2Uiaup ?Novo Nordisk held their 2024 MassBio Pharma Day?: https://lnkd.in/eurUNcvV Learn more about the #MassBioHub - our team is ready to help with your next event: https://lnkd.in/enVye8Rj

MassBio?and The Termeer Foundation are committed to supporting CEOs, entrepreneurs, and their networks by fostering meaningful connections and collaboration. Together, we aim to create a lasting impact on how CEOs and founders engage and grow with one another. Life sciences company founders and CEOs are?invited to apply to join the CEO & Founder Link, where they can attend exclusive quarterly events. These gatherings provide a safe, empowering space to share best practices, workshop challenges, and build lasting partnerships. Applications are accepted on a rolling basis - apply now: https://lnkd.in/eEujUbij

With Governor Healey's signature, we are embarking on another decade of innovation for patients through partnership and collaboration. On behalf of the MassBio community, I'd like to thank Governor Healey, Lieutenant Governor Driscoll, and Secretary Hao for spearheading the third iteration of the Life Sciences Initiative and our industry’s champions in House and Senate leadership for getting it across the finish line this session. The continued investment in infrastructure across the state and increases to the proven-effective Life Sciences Tax Incentive Program ensure that Team Massachusetts will have the tools to support innovation and the creation of lifesaving medicines and therapies for patients around the world while also lengthening our lead economically here at home.

We had an inspiring Friday in the #MassBioHub for our 2024 Patient Advocacy Summit. We were welcomed by Elsa Wilson LaVita, MBA, Director, Patient Advocacy, MorphoSys, followed by opening remarks from MassBio CEO & President Kendalle Burlin O'Connell, Esq. Wendy Poage, Head of Patient Advocacy at Servier Pharmaceuticals shared insights on creating a patient-centric culture. Courtney Dion and Joe Dion of The Dion Foundation sat on a panel with the CEO of Atamyo Therapeutics Stephane Degove, having a moving discussion on what it means to take the step from parent advocates to clinical trial funders. Biotechnology Innovation Organization SVP, External Affairs & Head, Patient Advocacy Center of Excellence Michele Oshman shared personal stories and gave a briefing on what's happening in Washington. Our final panel was "Elevating Black Voices to Achieve Better Health Outcomes" featuring Jessica Russo of the American Cancer Society, Dr. Erica Warner, ScD MPH and cancer survivor Jenina Tyler. Learn more about the initiative here: https://voices.cancer.org View all of the event photos: https://lnkd.in/ef8Ep4Qr Thank you to our sponsors! Sustaining: Massachusetts Life Sciences Center | Thermo Fisher Scientific | Vertex Pharmaceuticals Copper: Novartis | Harvard Pilgrim Health Care | Sanofi | Sumitomo Pharma America, Inc. Supporting: Ultragenyx #MassBioPatientAdvocacySummit | #PatientAdvocacySummit | #PatientDriven

On Thursday we held our MassBioDrive Fall 2024 Cohort Demo Day. #MassBioDrive is an accelerator program designed to advance breakthrough science while providing opportunities to innovators from all parts of the #lifesciences ecosystem. Twice a year, we support a small group of groundbreaking scientists by connecting them with business fundamental curriculum, mentorship, industry connections, and equity-free prizes – without taking anything in return. Congratulations to our five startups, who after an intensive eight-week program, highlighted their innovations to investors and industry leaders. Learn more: https://lnkd.in/eAztxEdd D2B3: https://d2b3.bio/ HarborSite: https://lnkd.in/eWtXt23t LybraBio: https://www.lybrabio.com/ Modulate Bio: https://lnkd.in/ertKYWGV RedPoint Oncology, Inc: https://lnkd.in/eeQTDCh6 View all the photos from Demo Day: https://lnkd.in/eAZANyXt

?????? ???????????? ???? ?????????????? ????????????: A patient advocacy group founded by two parents has partnered with a biotech company on a gene therapy for limb-girdle muscular dystrophy Type 2C/R5 - it was just cleared to start a clinical trial. DION FOUNDATION Co-Founder and President Courtney Dion discusses with Atamyo Therapeutics CEO Stephane Degove the many ways that patient advocate groups can support the work that biotech companies do. Full video: https://lnkd.in/g_8PCqpF The Studio at Kendall Square episodes are brought to you by MassBio. BiotechTV is brought to you by: Mispro | Breakthrough Properties | HSBC Innovation Banking | Theragent Inc | NYSE | Allucent | Klein Hersh

Congratulations to the team at Waltham-based Syndax Pharmaceuticals on the FDA approval! #MassBioMember #patientdriven

Senator Sal DiDomenico, who represents Kendall Square and serves as co-chair of the Life Sciences Caucus, delivered these remarks during the Senate’s debate on the economic development bond bill containing the third iteration of the Massachusetts Life Sciences Initiative (LSI). His remarks centered on the value of this industry for the economy and, more importantly, for patients like his own mother. Following debate in both chambers, the House and Senate voted to send the long-awaited package to Governor Healey for her signature.?

Two MassBio events hosted within 17 hours of each other were very different in most ways but had an essential common thread: patients. On Thursday night I had the pleasure of welcoming our latest #MassBioDrive cohort for their Demo Day, a culmination of the 8-week Drive accelerator program. It was exciting to hear about their science and see the five companies present to a room of potential investors and strategic partners that could help them. And just this morning we were back in the same room for the annual Patient Advocacy Summit. It was a packed agenda and room filled with emotional stories from parents, advocates, and leaders about fighting for their children, speaking with lawmakers, being a patient-centric biopharma company, and delivering on #healthequity. These two back-to-back convenings emphasize two foundational pieces of MassBio’s mission and Vision 2030 strategic roadmap: 1) support for the smallest and most innovative startups and 2) keeping patients at the center of everything we do and how we support our members. Thank you to the community for coming out to both and for all that you do. #PatientDriven #MassBioPatientAdvocacySummit